Validose delivers unique medication adherence solutions to improve clinical trial outcomes
Validose has raised $1.6M in total funding. The most recent round was Seed. The last funding was announced in January 2025.
Validose's investors include 10XBeta, Peter Bauer’s Family Office, Interstate Fusion Ventures.
Validose is headquartered in New York, United States.
Validose delivers unique medication adherence solutions to improve clinical trial outcomes
Validose is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Validose — Funding & Investors." VCBacked, January 6, 2025, https://www.vcbacked.co/company/validose. Accessed August 17, 2026.
VCBacked. (2025). Validose — Funding & Investors. Retrieved August 17, 2026, from https://www.vcbacked.co/company/validose
{{cite web |title=Validose — Funding & Investors |url=https://www.vcbacked.co/company/validose |website=VCBacked |access-date=August 17, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated